Our services

Advance your compounds to the clinic with confidence

We are seasoned specialists in chronic pain and neurodegenerative disease drug discovery with a deep understanding for Client needs. We have a proven track record of developing customer-specific solutions for our Clients to ensure project progress.
Read more arrow_forward

We deliver high quality information

We’re not just providing data, we provide valuable information and clear answers to complex biological questions.

We accelerate your decision-making

Thanks to our highly experienced team, proprietary discovery platform and streamlined operations, we can shorten your project lead times.

Fast access to ground-breaking assays

We develop highly innovative in vitro assays based on complex biology that provide translationally relevant information.


An approach you can trust

We provide fully collaborative support, tailored to each individual study. Our Clients value our interactive and open communication style, our high capacity, quality and delivery precision needed for projects from target discovery and screening to lead optimization.

Read more

Our platform

Our unique discovery platform

Our team of highly experienced neurobiologists, stem cell researchers and engineers, has developed a unique and patent protected discovery platform which enables development of innovative in vitro assays of enhanced translational value.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news, newsletters and to learn about upcoming events.

Read more

May 16-17, 2022
The Neuro4D conference takes place in Mainz, Germany on May 16-17, 2022. With a focus on neurodegenerative disease drug discovery,...
May 10-12, 2022
Advances in Cell-based Screening
ELRIG’s meeting on Advances in Cell-based Screening 2022 takes place at AstraZeneca in Gothenburg, Sweden on May 10-12, 2022. The...
May 8-10, 2022
Target to Patient
The Target to Patient meeting takes place at the Wellcome Genome Campus in Hinxton, UK on May 8-10, 2022. The...
March 15-20, 2022
AD/PD 2022
The AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders took place in Barcelona, Spain and...
November 8-11, 2021
Neuroscience 2021
The Neuroscience 2021 takes place on November 8-11 as a virtual meeting. During the conference, we will present several posters...
June 17, 2021
Webcast - The importance of non-neuronal cells in chronic pain – a Drug Discovery perspective
Event info: Pain drug discovery has historically been challenging with few new therapeutics reaching the market. In this webcast, Cellectricon...
Cellectricon receives funding from Takeda’s open innovation platform
Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of a new research...
February 3, 2021
Webcast - New translational biomarkers and functional studies to support drug discovery and drug development for Alzheimer’s disease
Event info: In this three-part webcast, Professor Henrik Zetterberg first provided an overview presentation on recent developments in biomarker-supported drug...
November 19, 2020. 8 am PST / 11 am EST / 5 pm CET
Webinar - Discovery of NaV1.2 Modulators for Treating Autism Spectrum Disorder
Webinar description: Recent discoveries have shown that loss-of-function variants of SCN2A are causal for a number of neurodevelopmental disorders, including autism spectrum...

Get the latest news & events – sign up for our newsletter

Read about our Privacy Policy